Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“UMNDs may occur because of a traumatic event, nontraumatic event, or inherited or sporadic neurodegenerative disease.1,3–8”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedTissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · cited 1×
“Atrial fibrillation (AF): AF is an important risk factor for stroke, increasing risk two- to five-fold depending upon the age of the individual concerned [50].”
BackgroundIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149 · cited 1×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“A study reported that a 5–6 mm Hg reduction in BP lowered the relative risk of stroke by 42% [44].”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264 · cited 3×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundMethod
Research works printed but not linked: 2
- Rollin B.E. The Experimental Animal in Biomedical Research: Care, Husbandry and Well-Being: An Overview by Species Kesel M.L. CRC Press Boston, MA, USA 1995
- VE O.C. GA D. MR M. DW H. Animal models of stroke versus clinical stroke: Comparison of infarct size, cause, location, study design, and efficacy of experimental therapies Animal Models for the Study of Human Disease Michael Conn P. Academic Press Waltham, MA, USA 2013 531 568
Cited by
Items 701–800 of 1,001
Amikam, U., Badeghiesh, A. M., Baghlaf, H. A., Brown, R. N., & Dahan, M. H. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07627-7 · Cited by 2
“A CVA results in a permanent neurologic deficit secondary to tissue necrosis [5].”
Safiullov, Z. Z., Izmailov, A., Аршалуйсович, М. В., Хомяков, А. Е., Boychuk, N. V., Nigmetzyanova, M. V., Siraeva, A. R., Targachev, S. S., Valiullin, V. V., Islamov, R. R., et al. (2024) · Sechenov Medical Journal · doi:10.47093/2218-7332.2024.15.2.13-27 · Cited by 2
Ibeh, S., Babale, I., Morah, A. C., Khachab, M. Y., Eid, A. H., & Kobeissy, F. H. (2024) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-031-62131-4_7 · Cited by 3
Wang, Y., Zhang, H., Hao, Y., Jin, F., Tang, L., Xu, X., 何志义, & Wang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35864 · Cited by 2
“Stroke, which is the second leading cause of mortality and a major contributor to disability globally, is most highly prevalent in developing countries [19].”
BackgroundEnhancing Acute Ischemic Stroke Diagnosis Using IoMT and Deep Learning Technologies
El-Sheikh, M. M., Bayoumy, A., Ahmed, N. M., Eldeeb, A. M., Rabea, F. I., Nawar, A. A., Khattap, M. G., Hassan, H. G. E. M. A., Mostafa, M., Ibrahim, N., et al. (2024) · International Telecommunications Conference (ITC-Egypt) · doi:10.1109/itc-egypt61547.2024.10620484 · Cited by 2
“Stroke is a critical medical emergency that stands as the second primary cause of morbidity and mortality worldwide [1].”
BackgroundCharatpangoon, P., Delannoy, P., Vega, F., Gilliland, R., Addeh, A., Mhajna, M., Sheronick, R., McDougall, C. C., Lee, T.-Y., Barber, P. A., et al. (2024) · Physica Medica · doi:10.1016/j.ejmp.2026.105902 · Cited by 2
Girish, B. S., Nikitha, B. S., Roopa, K., Meghana, C. S., & Srinivasan, R. (2024) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2024.100197 · Cited by 4
Pretorius, L., Petersen-Ross, K. S., & Smith, C. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118822 · Cited by 3
Webb, R. J., Al‐Asmakh, M., Banach, M., & Mazidi, M. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104186 · Cited by 3
Applications and Developments of Gene Therapy Drug Delivery Systems for Neurological Disorders
Nguyen, N. H., Nguyen‐Thi, P., Nguyen, T. T., Bui, V. K. H., Nguyen, N. T. T., & Giau, V. V. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400269 · Cited by 3
Vamshikrishnapatel, K., Biswas, R., Kumar, V. L., & Ojha, V. S. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085078 · Cited by 4
Yan, D., Zhao, J., Ma, Y., & Ma, H. (2024) · Displays · doi:10.1016/j.displa.2024.102944 · Cited by 3
Deng, Q., Yang, Y., Bai, H., Li, F., Zhang, W., He, R., & Li, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70198 · Cited by 14
“Stroke is globally the second most prevalent cause of death and the third contributor to both mortality and disability (Potter, Tannous, and Vahidy 2022; Kuriakose and Xiao 2020; Mosconi and Paciaroni 2022).”
Muhith, A., & Supu, N. M. (2024) · Journal of Applied Nursing and Health · doi:10.55018/janh.v6i2.263 · Cited by 3
Satar, A. M., Othman, F. A., & Tan, S. C. (2025) · Bio-Medical Materials and Engineering · doi:10.1177/09592989241306679 · Cited by 2
Geniposide protects against cerebral ischemic injury by targeting SOX2/RIPK1 axis
He, X., Zhang, Y., Xu, C., Zhang, R., & Li, Y. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04079-x · Cited by 3
“It has been reported that the etiology of IS is ascribed to cerebral artery occlusion, which triggers neuronal death, glial activation, and disruption of the blood–brain barrier (Kuriakose and Xiao 2020).”
The role of myeloperoxidase in the pathogenesis of stroke
Liu, W., Wang, Y.-R., Wu, H., Cui, W., & Xu, X. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149705 · Cited by 4
Liang, X., Cao, C., Liu, N., Chen, D., Liu, T., Ma, H., Liu, J., Wu, T., & Niu, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1611226 · Cited by 3
Gao, W., Sun, J., Yu, L., She, J., Zhao, Y., Cai, L., Chen, X., & Zhu, R. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1570662 · Cited by 2
Dubois, L., Dussault, B., Ribon‐Demars, A., Poulin, V., Ouellet, M., & Beaulieu‐Bonneau, S. (2025) · Brain Injury · doi:10.1080/02699052.2025.2513616 · Cited by 2
“It is the second leading cause of mortality globally, affecting approximately 13.7 million people annually (1).”
InfluentialZhang, Q., Han, S., Zheng, Y., Li, J., Ma, L., Tan, J., Kang, X., Gong, R., Chen, S., & Shi, S. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10461-z · Cited by 2
“Epidemiological data show an annual incidence exceeding 30,000 stroke-related hospitalizations world-wide (Kuriakose and Xiao 2020).”
Hosseini, S., Samiei, A., & Ahmadi, M. (2025) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2025.3583144 · Cited by 4
“W ALKING-RELATED disabilities affect millions of individuals worldwide [1], [2], and assistive walking devices, such as robotic exoskeletons and assistive robots, have been developed to restore functional movement to individuals with walking impairments [3].”
Cui, Z., Schomburg, L., Holleczek, B., Hybsier, S., Köhrle, J., Brenner, H., & Schöttker, B. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.07.039 · Cited by 2
Li, M. (2021) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2021.09.065 · Cited by 2
Zhao, N., Niu, R., Zhu, Y., & Yu, C. (2021) · Ibrain · doi:10.1002/j.2769-2795.2021.tb00059.x · Cited by 2
Zhang, A., Han, F., & Piao, C. (2022) · Medicine · doi:10.1097/md.0000000000031823 · Cited by 2
“As the second leading cause of death and the leading cause of disability, stroke seriously harms human’s health globally.[1] Diabetes, as a chronic, lifelong, severe metabolic health problem characterized by hyperglycemia, is a well-established independent risk factor for stroke and is associated with increased disabi…”
BackgroundHemorrhagic stroke as a rare complication of opening the permanent dialysis catheter by Reteplase
Rasouli, M., Anzali, B. C., & Goli, R. (2023) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2023.108088 · Cited by 2
The effect of aspirin therapy on the increasing of Barthel Index score in stroke patients
Alifiar, I., Kamal, H. F., & Sukmawan, Y. P. (2021) · Pharmacy Reports · doi:10.51511/pr.3 · Cited by 2
Effect of initial stroke care bundle on clinical outcomes among patients with acute ischemic stroke
Mohamed, R. D., Hamad, A. H., & Mohamed, W. R. A. (2023) · Egyptian Nursing Journal · doi:10.4103/enj.enj_15_22 · Cited by 2
Role and function of cPLA2 in CNS trauma and age-associated neurodegenerative diseases
Sarkar, C., & Lipinski, M. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21800-2.00015-4 · Cited by 2
Analysis of Early Stroke Diagnosis Based on Brain Magnetic Resonance Imaging using Machine Learning
Kandaya, S., Abdullah, A. R., Saad, N. M., Azman, I. H., Shair, E. F., & Ali, N. H. (2023) · Journal of Advanced Research in Applied Sciences and Engineering Technology · doi:10.37934/araset.32.3.241255 · Cited by 4
Düvel, J. A., Baumgartner, A., Grosser, J., Kreimeier, S., Elkenkamp, S., & Greiner, W. (2023) · Professional Case Management · doi:10.1097/ncm.0000000000000701 · Cited by 3
“However, current care structures continue to focus on acute and short-term treatments rather than preventive and long-term interventions (Kuriakose & Xiao, 2020; Norrving et al., 2018; Sachverständi-genrat [SVR], 2018; Stumm et al., 2019).”
BackgroundGong, Z., Ingabire, H. N., Yao, S., Liu, C., & Chen, Y. (2023) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc40787.2023.10340845 · Cited by 2
“Early diagnosis and aggressive medication in the form of thrombolytic drugs are shown to be essential for the effective treatment of stroke [3].”
BackgroundNanomedicines in Treatment of Cardiovascular Diseases
Tanveer, A., Akhtar, B., Sharif, A., Anwar, M. I., Khan, H. Z., Büyüker, S. M., Javaid, M. M. Z., Akhtar, K., & Zubair, H. M. (2023) · Learning materials in biosciences · doi:10.1007/978-981-99-7626-3_11 · Cited by 2
Basalova, N. A., Станиславович, Д. С., Yurshev, Y. A., Primak, A. L., Efimenko, A. Y., Va, T., & Karagyaur, M. N. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040074 · Cited by 2
Sun, D., Luo, F., Fang, C., Zhu, Q., & Li, C. (2024) · Medicine · doi:10.1097/md.0000000000037482 · Cited by 2
“[7] Recombinant tissue plasminogen activator stands as the sole FDA-approved medication for the Institutional review board approval and informed consent were not required in the current study because research data are publicly available and all patient data are de-identified.”
BackgroundUnlocking the Future of Stroke Diagnosis-Bayesian CNN and MRI Fusion
Beevi, F., Santhi, N., & Ramasamy, N. (2024) · International Conference on E-mobility, Power Control and Smart Systems (ICEMPS) · doi:10.1109/icemps60684.2024.10559315 · Cited by 2
“Timely medical attention is vital, as brain damage and recovery potential hinge on prompt treatment [8].”
Khairi, N. A. A. M., Hanafi, M. H., Kassim, N. K., Ibrahim, A. H., & Ahmad, W. M. A. W. (2024) · Cureus · doi:10.7759/cureus.68332 · Cited by 2
“When there is a head injury or cerebral aneurysm, blood builds up in the brain's subarachnoid space, resulting in subarachnoid hemorrhage [9].”
BackgroundGarrido, M. A., Álvarez, E., Acevedo, F. L., Moyano, Á. I., Castillo-Núñez, N. P., & Cavada, G. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4178113 · Cited by 2
“Stroke is one of the main causes of serious long-term disability, deterioration of the quality of life, and socioeconomic costs[1,2].”
Brinholi, F. F., Michelin, A. P., Matsumoto, A. K., Semeão, L. D. O., Almulla, A. F., Supasitthumrong, T., Tunvirachaisakul, C., Barbosa, D. S., & Maes, M. H. J. (2022) · Research Square · doi:10.21203/rs.3.rs-1979784/v1 · Cited by 2
FAKTOR RESIKO STROKE PADA USIA MUDA: TINJAUAN LITERATUR
Adi, M. A., Arafat, R., & Irwan, M. (2022) · Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing) · doi:10.33023/jikep.v8i1.798 · Cited by 4
Investigation of cerebrovascular activity of new GABA-derived short peptides
Adamyan, N. H., Shamilyan, Q. M., Zhamharyan, A. G., Topchyan, H. V., & Balasanyan, M. G. (2022) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-2022.16.4-89 · Cited by 1
Vitamin D levels and oral health in stroke patients during inpatient rehabilitation
Yakşi, E., & Horasan, N. (2023) · Journal of Oral Rehabilitation · doi:10.1111/joor.13415 · Cited by 1
Enfermedad cerebro vascular isquémica diagnóstico y tratamiento.
Rodríguez, F. D. A., Pavón, M. E. A., Chamorro, J. D. P., García, S. L. M., Aguirre, C. D. L., Vásquez, F. A. R., & Ronquillo, G. A. C. (2023) · The Ecuador Journal of Medicine · doi:10.46721/tejom-vol6iss1-2023-28-41 · Cited by 5
André, M. L. P., Morato, B. B., Costa, D. N., Dornelas, D. B. D. A., Filho, L. C. V. B., Pereira, L. F. M., Santos, F. C. D., & Ferreira, I. F. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n4-415 · Cited by 1
Banjari, I. (2023) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-2023.17.3-31 · Cited by 1
Neuroprotective Activity of Olea Europaea and Malus Domestica in Stroke Model of Albino Rat
Asif, K., Khan, H. M., Siddique, M., Khan, T. A., Syed, F., Riaz, H., Raza, S. A., Malik, A. R., & Ahmad, W. (2024) · Advances in Pharmacology and Pharmacy · doi:10.13189/app.2024.120104 · Cited by 1
Udhoji, S. P., Raghuveer, R., & Kovela, R. K. (2024) · F1000Research · doi:10.12688/f1000research.142153.1 · Cited by 1
Engineering enzymatic- and photo-crosslinked silk-based hydrogels for regenerative medicine
Oliveira, E. P., Maia, F. R., Reis, R. L., & Oliveira, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-96017-5.00009-1 · Cited by 1
Decompressive craniectomy: A primer for acute care practitioners
Brindley, P. G., Sanderson, M., Anderson, D., & O'Kelly, C. J. (2024) · Journal of the Intensive Care Society · doi:10.1177/17511437241237760 · Cited by 1
“11 This causes cytotoxic edema, as cellular contents spill out.”
BackgroundUnderstanding Antithrombotic Agents for Rehabilitation Therapy: A Comprehensive Narrative Review
Matsumoto, S., Ohama, R., Hoei, T., Tojo, R., & Nakamura, T. (2024) · Cureus · doi:10.7759/cureus.58302 · Cited by 1
“…used in the initial treatment and prevention of recurrence (secondary prevention) of stroke, successful use of antithrombotic agents will not adversely affect rehabilitation treatment, but will improve patients' activities of daily living (ADL), thereby improving their quality of life (QOL) [2].”
BackgroundStem cell grafts enhance endogenous extracellular vesicle expression in the stroke brain
Brooks, B., D’Egidio, F., Borlongan, M. C., Borlongan, M. C., & Lee, J.-Y. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110999 · Cited by 1
“After a stroke, the brain undergoes an acute repair process (Jones and Adkins, 2015; Regenhardt et al., 2020; Jiao et al., 2021), but this is often followed by secondary cell death mechanisms that worsen the condition (S¸ekerda ˘ g et al., 2018; García-Pupo et al., 2020; Kuriakose and Xiao, 2020).”
Sun, R., Jiang, Z., & Sun, Y. (2024) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000010623 · Cited by 1
The Impact of Plant-Based Diets on Cardiovascular Disease and Its Risk Factors
Allen, K., Bassin, S. R., & Ostfeld, R. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-63083-5_26 · Cited by 1
POST-STROKE VISUAL FIELD DEFECTS AND OTHER OPHTHALMOLOGICAL ABNORMALITIES: A RETROSPECTIVE STUDY
Rokhade, R., & Jain, P. K. (2024) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2024v17i9.52536 · Cited by 1
“Stroke is a leading cause of morbidity and mortality worldwide and results from an acute disruption of cerebral blood flow that leads to focal or global neurological deficits [1].”
BackgroundBiomarkers of Acute Brain Injury
Barmpagiannos, K., Lazaridis, N., Apostolopoulou, A., & Fyntanidou, B. (2024) · Neuroglia · doi:10.3390/neuroglia5040024 · Cited by 1
Khongrum, J., Yingthongchai, P., Tateing, S., & Kaewkaen, P. (2024) · Marine Drugs · doi:10.3390/md22100451 · Cited by 1
“According to several sources of evidence, acute ischemic stroke occurs as a result of multiple factors, such as disruption of the blood-brain barrier and vascular changes that reduce blood flow to the brain [1,2].”
BackgroundMosqueda, M. L. M., Ruiz‐Oropeza, S. Y., González-Barrios, J. A., Jaimez, R., Peña‐Ortega, F., & Acevedo, C. G. (2024) · Drug Development Research · doi:10.1002/ddr.70012 · Cited by 1
“Cerebrovascular events (CVEs) have emerged as the second leading cause of death and the foremost cause of long ‐ term disability worldwide, with ischemic events being the most prevalent (Kuriakose and Xiao 2020; Hermann et al. 2019).”
Kirkham, A. M., Fergusson, D. A., Presseau, J., McIsaac, D. I., Shorr, R., & Roberts, D. J. (2024) · JMIR Research Protocols · doi:10.2196/60326 · Cited by 1
“…forms of atherosclerotic occlusive disease (CVD, CAD, PAD, and polyvascular disease) will be examined within both systematic reviews as the underlying pathophysiology [50-52], and guideline-recommended cardiovascular medications for medical management of these diseases [7-11] are nearly identical.”
Zeng, X., Shao, J., Pan, D., Zeng, S., Wang, Z., Yao, X., Li, H., Xiao, W., & Yu, Y. (2024) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2024.106084 · Cited by 2
Unveiling Stroke: Biomarkers and Diagnostic Strategies
Wadan, A. S., & Mohamed, W. (2024) · Nutritional neurosciences · doi:10.1007/978-981-97-6818-9_4 · Cited by 1
İnme Hastalarında Öz Yönetim ve İnmeden Korunmanın Sağlık Politikalarındaki Önemi
Yavuz, A. U., & Mutlu, H. (2024) · Medical Journal of Western Black Sea · doi:10.29058/mjwbs.1490182 · Cited by 1
Phosphodiesterase 4 inhibition as a novel treatment for stroke
Zhong, J., Yu, X., & Lin, Z. (2025) · PeerJ · doi:10.7717/peerj.18905 · Cited by 2
“It is the third leading cause of death in the world ( Chen et al., 2017b ; Campbell et al., 2019 ; Kuriakose & Xiao, 2020 ).”
Assessment of Upper Body Kinematic Using Multiple Inertial Measurement Units
Rahman, M. M., Gan, K. B., Woon, Y. H., Aziz, N. A. A., Huong, A. K. C., & Sim, K. S. (2025) · IEEE Sensors Journal · doi:10.1109/jsen.2025.3534800 · Cited by 1
“In order to be recruited, subjects had to be between the ages of 20 and 54 years as the proportion of strokes in individuals aged 20–54 years rose from 12.9% to 18.6% of all cases worldwide between 1990 and 2016 [36].”
InfluentialTaboada-Alquerque, M., & Olivero‐Verbel, J. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2460591 · Cited by 1
“…(Zhao et al. 2022). this blockage results in a deficient supply of blood and oxygen to the brain, leading to the rapid death of brain cells (Kuriakose and Xiao 2020). some of the molecular mechanisms of the pathophysiology of ischemic stroke include excitotoxicity, calcium over-load,…”
The Endocannabinoid System as a Target for Ischemic Stroke Therapy
Stork, S. D. S., Mathias, K., dos Santos, D., Lippert, F. W., Machado, R. S., Maragno, V. D. A., Joaquim, L. D. S., Stork, S. S., de Bitencourt, R. M., Bobinski, F., et al. (2025) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0017 · Cited by 2
“34 , 35 In general, the ischemic cascade is stimulated by a series of physiological and molecular events, mainly related to neuroin fl ammation and oxidative stress.”
Haonan, C., Shuhan, Z., Runlei, Z., Pei-lin, C., & Shengxian, W. (2025) · Journal of Medical Biochemistry · doi:10.5937/jomb0-57208 · Cited by 4
“Stroke is characterised by the sudden cessation of blood supply to specific regions of the brain, leading to a cascade of pathophysiological events, including neuronal injury, inflammation, and oxidative stress (2, 3).”
Fernandes, J. V. A., Ramos, J. M., & Holanda, M. M. D. A. (2025) · Neurological Research · doi:10.1080/01616412.2025.2487873 · Cited by 1
“Acute ischemic strokes are characterized by the formation of thrombi that obstruct cerebral arteries, leading to ischemia and subsequent neuronal injury [30,31].”
Huang, L., Cao, X., Wu, J., Quan, Y., Zuo, Y., Zhang, F., & Meng, Z. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70049 · Cited by 1
Therapeutic effect of erythropoietin and its derivatives in the treatment of acute ischemic stroke
Rama, R., & Torrella, J. R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004101 · Cited by 2
Li, W., Wu, J., Hu, Z., Zhang, J., Ye, G., Luo, F., Zeng, Z., & Luo, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1553337 · Cited by 2
Zong, Y., & Gu, Q. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1576453 · Cited by 1
“Unlike ischemic stroke, which results from blockages in blood flow to the brain, hemorrhagic stroke is caused by ruptured blood vessels, leading to blood accumulation that can cause brain cell damage (2).”
Zhang, L., Li, Y., Fan, W., & Xue, H. (2025) · Annals of Human Genetics · doi:10.1111/ahg.12599 · Cited by 1
“Effective IVs must satisfy three criteria: (Kuriakose and Xiao 2020) IVs should have a strong correlation with SLE; (Sharrief and Grotta 2019) IVs should not be associated with any potential confounding factors; and (Barthels and Das 2020) IVs should only affect the stroke through SLE, without any…”
Reliability and validity of the Turkish executive function performance test in people with stroke
Gürbüz, D. A., Öztürk, L. K., Temuçin, K., Gürlek, S., Umay, E., & Akı, E. (2025) · Applied Neuropsychology Adult · doi:10.1080/23279095.2025.2501670 · Cited by 1
Peng, X., Dai, Y., Chen, J., Lü, J., Zhou, D., Ge, F., Liu, P., & Zhou, X. (2025) · Pharmaceuticals · doi:10.3390/ph18050728 · Cited by 1
“IS is the most common kind of stroke, accounting for approximately 87% of all cases [5].”
Huang, H., Xiong, Y., Yao, Y., & Zeng, J. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04870-x · Cited by 1
“In recent decades, the incidence of stroke has been steadily increasing, imposing a significant disease burden on low-and middle-income countries [3] and ranking as the second leading cause of death worldwide [1].”
Tang, Z., & Liu, C. (2025) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0328 · Cited by 1
Neurochemical exploration for therapeutic advancements in stroke
Barik, A., Malik, N., Dubey, A., Karmarkar, G., Kumari, A., Mukherjee, U., Ghosh, B., Datta, A., Borah, A., & Bhattacharya, P. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.05.308 · Cited by 1
Wulaningsih, R., Hudiyawati, D., & Subrata, S. A. (2025) · Malahayati International Journal of Nursing and Health Science · doi:10.33024/minh.v8i3.939 · Cited by 1
“Delayed management often results in worse functional outcomes, underscoring the need for timely and effective treatment aimed at restoring cerebral perfusion and minimizing disability (Kuriakose & Xiao, 2020).”
Cheng, X., Peng, T., Li, J., & Li, H. (2025) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2025.108373 · Cited by 4
Brain Stroke Prognosis: a Fusion of Machine Learning and Deep Learning
Suresh, A., Sambasiva, V., Somya, P., Yashmitha, G., Sagar, K. S., & Sai, N. V. (2025) · International Conference on Data Science and Business Systems (ICDSBS) · doi:10.1109/icdsbs63635.2025.11031973 · Cited by 1
“Millions of people every year suffer from strokes, and most have to contend with difficult recoveries as a result of a lack of adequate diagnosis and treatment systems [2].”
Tiwari, I., Arora, A., & Rajawat, J. S. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700060 · Cited by 2
Chackochan, A., Reghunath, S. R., Guddattu, V., Thunga, G., Nagri, S. K., Shenoy, R. P., Shenoy, V. P., & Acharya, L. D. (2025) · Nutrition and Health · doi:10.1177/02601060251359708 · Cited by 3
“In contrast, haemorrhagic stroke, which often occurs due to factors like hypertension and vascular malformations, may not show the same association with vitamin D levels (Kuriakose and Xiao, 2020).”
Hemodynamic simulation analysis of tandem carotid artery stenosis based on a patient-specific case
Cao, J., Tan, Z., Tang, Y., Liu, Z., Huang, J. V., Huo, G., Yao, Z., Zhou, Y., & Zhou, D. (2025) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2025.112907 · Cited by 1
Diffusion Tensor Tractography Studies for Causes of Dysphagia After Stroke: A Systematic Review
Jang, W.-H., Lee, S., & Lee, S.-H. (2025) · Brain Sciences · doi:10.3390/brainsci15090925 · Cited by 1
Jiang, Y., Deng, M., Song, K., Wang, Z., Xu, W., Feng, T., Chen, S., Wan, C., Ma, X., & Li, F. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1619727 · Cited by 1
Peracho, L., Martínez‐Alonso, E., Bermúdez, I., Cruz-Culebras, A., Mimbrera, A. D. F., Fandiño, E., Madrona, S. G., Matute-Lozano, M. C., Méndez-Cendón, J. C., Lechuga, R. V., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178333 · Cited by 1
“The risk factors associated with stroke are diverse and include age, sex, and race/ethnicity, as well as modifiable factors such as hypertension, smoking, obesity, alcohol consumption, diabetes mellitus, low physical activity, atrial fibrillation (AF), and sleep apnea [5].”
Manrique-Gutiérrez, G., Roldán-Valadéz, E., Ternovoy, S. K., Ramirez-Nava, A. G., Montes-Ugaldo, A., & Quinzaños-Fresnedo, J. (2025) · Cureus · doi:10.7759/cureus.91484 · Cited by 2
Liang, J., Hopf, S., & Paton, I. (2025) · Aphasiology · doi:10.1080/02687038.2025.2555866 · Cited by 1
Li, G., & Wei, W. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186406 · Cited by 1
“Despite notable advancements in pharmacological treatments, endovascular therapy, and post-stroke rehabilitation, stroke remains a primary cause of disability and mortality, especially in patients admitted to intensive care units (ICUs) [3].”
Lee, D. H., Park, Y., Choi, S., Kim, J., Yee, J., & Gwak, H. S. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038873 · Cited by 2
Feng, L., Zhu, L., & Wang, B. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1627446 · Cited by 1
“Stroke poses a major threat to China’s public health and is a severe chronic non-communicable disease, characterized by high morbidity, disability, mortality, recurrence, and economic burden (1, 2).”
ALNasser, M. N., Malik, N., Ahmed, A., Newman, A. H., Mellor, I. R., & Carter, W. G. (2025) · Brain Sciences · doi:10.3390/brainsci15101073 · Cited by 1
“Collectively, this drives cell death through the apoptotic and necrotic death of the cells of the neurovascular unit (neurons, astrocytes, pericytes, and vascular endothelial cells) [1,8].”
InfluentialMostaghimi, M., & Heidarianpour, A. (2025) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2025.2566140 · Cited by 1
Younas, A., Qadri, M., Noor, R., Pirzada, L., Khan, T., Anwar, M., Shahid, I., Raja, H. A. A., Munir, A., Sathian, B., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08492-1 · Cited by 1
“Stroke is a common neurological disease characterized by damage to brain tissue either due to a lack of blood supply or bleeding within the brain parenchyma, leading to neu - ronal cell damage [ 1, 2 ].”
Encephalomalacia from Physical Trauma in an Adult: A Case Report and Review of Literature
Sorathia, A. Z., Khindri, N. M., Akhai, A., Villegas, K. J., Isshak, R., & Michael, P. (2025) · International Medical Case Reports Journal · doi:10.2147/imcrj.s547076 · Cited by 1
“2,8,15 Encephalomalacia is best identified by neuroimaging, as illustrated by our patient.”
Characterizing Non‐Traumatic Spinal Cord Injury in Neonatal Sprague Dawley Rats
Ridlen, R. M., Burke, M., Wesley, C., Le, H. T., Farrell, L., McGrath, K. C. Y., & Gorrie, C. A. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70086 · Cited by 1
“…to that commonly seen in the brain following ischemic stroke with disruption to the vasculature leading to reduced blood supply and triggering events that lead to necrosis and loss of neuronal function including excitotoxicity and inflammation (Kuriakose and Xiao 2020; Mergenthaler et al. 2004).”
InfluentialAttention-based Deep Learning Framework in the Classification of Post-Stroke Kinematic Parameters
Pantonial, R., & Simić, M. (2025) · Procedia Computer Science · doi:10.1016/j.procs.2025.09.125 · Cited by 3
Unveiling the potential of neuron-targeted dendriplexes for siRNA delivery using a PNS-CNS-on-Chip
Spencer, A. P., Xavier, M., Guimarães, S. C., Vilaça, A., Ionescu, A., Calmeiro, T., Santos, R., Salinas, D. E. C., Martins, R., Gómez-Lázaro, M., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114422 · Cited by 3
Tang, X., Cheng, G., Chen, S., Yao, L., Lu, L., Shen, C., Feng, L., Zhang, W., Xu, N., & Wang, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05420-4 · Cited by 1
“Delays in diagnosis and treatment further compromise outcomes [5], and current therapies primarily address the acute event rather than its upstream causes [6].”
Metadata
- Authors
- Kuriakose, D., & Xiao, Z.
- Affiliations
- Monash University (AU)
- Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia
- ORCID
- Kuriakose, Diji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7609
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589849
- OpenAlex
- W3093285665
- Semantic Scholar
- f44478fa13b48c2e68d010e69172d6d21ab09e66
- Cited by
- 1,350
- References
- 189
- Citations by year
- 2026: 154 · 2025: 291 · 2024: 346 · 2023: 300 · 2022: 196 · 2021: 63
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Apex Biotech Research (NA)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- stroke, ischemic stroke, stroke pathophysiology, stroke treatment, reperfusion therapy, neurological damage, animal models of stroke, stroke rehabilitation, stroke prevention, therapeutic target, post-stroke care
- MeSH terms
- Stroke Rehabilitation, Animals, Fibrinolytic Agents, Humans, Risk Factors, Neuroprotective Agents, Stroke, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


